Chemotherapeutic treatments: A study of the interplay among drug resistance, toxicity and recuperation from side effects

Bulletin of Mathematical Biology

Volumn 59, Issue 2, 1997, Pages 205-232

  Costa, M I S ^a   Boldrini, J L ^b  

^a LABORATÓRIO NACIONAL DE COMPUTAÇÃO CIENTÍFICA   (Brazil)

^b UNIVERSITY OF CAMPINAS   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

ARTICLE; BIOLOGICAL MODEL; CANCER CHEMOTHERAPY; CANCER CONTROL; CELL DEATH; CLINICAL PROTOCOL; DRUG CYTOTOXICITY; DRUG EFFECT; DRUG RESISTANCE; HUMAN; MATHEMATICAL MODEL; MATHEMATICS; NEOPLASM; PATHOLOGY; SIDE EFFECT;

EID: 0031104756     PISSN: 00928240     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02462001     Document Type: Article

References (31)

1. Bellomo, N. and G. Forni. 1994. Dynamics of tumor interaction with the host immune system. Math. Comput. Modelling 20, 107-122.
2. Bernardo Strada, M. R., G. Bernardo and G. Robustelli Della Cuna. 1983. Principi di immunoterapia antitumorale. In Manuale de Oncologia Medica, G. Bonadonna (Ed). Paris: Masson.
3. Clarke, F. H. 1983. Optimization and Nonsmooth Analysis. New York: Wiley.
4. Coldman, A. J. and J. H. Goldie. 1983. A model for the resistance of tumor cells to cancer chemotherapeutic agents. Math. Biosci. 65, 291-307.
5. Coldman, A. J. and J. H. Goldie. 1986. A stochastic model for the origin and treatment of tumors containing drug-resistant cells. Bull. Math. Biol. 48, 279-292.
6. Costa, M. I. S., J. L. Boldrini and R. C. Bassanezi. 1992. Optimal chemical control of populations developing drug resistance. IMA J. Math. Appl. Med. Biol. 9, 215-226.
7. Costa, M. I. S., J. L. Boldrini and R. C. Bassanezi. 1994. Optimal chemotherapy; a case study with drug resistance, saturation effect and toxicity. IMA J. Math. Appl. Med. Biol. 11, 45-59.
8. Costa, M. I. S., J. L. Boldrini and R. C. Bassanezi. 1995a. Drug kinetics and drug resistance in optimal chemotherapy. Math. Biosci. 125, 191-209.
9. Costa, M. I. S., J. L. Boldrini and R. C. Bassanezi. 1995b. Chemotherapeutic treatments involving drug resistance and level of normal cells as a criterion of toxicity. Math. Biosci. 125, 211-228.
10. Eisen, M. 1978. Mathematical Models in Cell Biology and Cancer Chemotherapy. Lecture Notes in Biomathematics, Vol. 30. New York: Springer-Verlag.
11. Goldie, J. H. and A. J. Coldman. 1979. A mathematical model for relating the drug sensitivity of tumors to their spontaneous mutation rate. Cancer Treat. Rep. 63, 1727-1733.
12. Harnevo, L. and Z. Agur. 1992. Drug resistance as a dynamic process in a model for multistep gene amplification under various levels of selection stringency. Cancer Chemother. Pharmacol. 30, 469-476.
13. Herson, J. 1980. Evaluation of toxicity: statistical considerations. Cancer Treat. Rep. 64, 463-468.
14. Kimmel, M. and D. E. Axelrod. 1990. Mathematical models for gene amplification with application to cellular drug resistance and tumorigenicity. Genetics 125, 633-644.
15. Kimmel, M., D. E. Axelrod and G. M. Wahl. 1992. A branching process model of gene amplification following chromosome breakage. Mut. Res. 276, 225-239.
16. Kuznetsov, V. A., I. A. Makalin, M. A. Taylor and A. S. Perelson. 1994. Nonlinear dynamics of immunogenic tumors: parameter estimation and global bifurcation analysis. Bull. Math. Biol. 56, 295-321.
17. Marusic, M., Z. Bajzer, S. Vuk-Pavlovic and J. P. Fryer. 1994. Tumor growth in vivo and as multicellular spheroids compared by mathematical models. Bull. Math. Biol. 56, 617-631.
18. Mohler, R. R., K. S. Lee, A. L. Asachenkov and G. I. Marchuk. 1994. A system approach to immunology and cancer. IEEE Trans. Syst. Cybernetics 24, 632-641.
19. Murray, J. M. 1990a. Optimal control for a cancer chemotherapy problem with general growth and loss functions. Math. Biosci. 98, 273-287.
20. Murray, J. M. 1990b. Some optimal control problems in cancer chemotherapy with a toxicity limit. Math. Biosci. 100, 49-67.
21. Murray, J. M. 1995. An example of the effects of drug resistance on the optimal schedule for a single drug in cancer chemotherapy. IMA J. Math. Appl. Med. Biol. 12, 55-71.
22. Schandl, F. R. 1989. Optimal treatment strategies in cancer chemotherapy. Forschungsbericht Nr. 116, Institut für Ökonometrie, OR und Systemtheorie, Technische Universität Wien.
23. Skipper, H. E. 1983. The forty year old mutation theory of Luria and Delbruck and its pertinence to cancer chemotherapy. Adv. Cancer Res. 40, 331.
24. Swan, G. W. 1987. Tumor growth models and cancer chemotherapy. In Cancer Modeling, J. R. Thompson and B. W. Brown (Eds). New York: Dekker.
25. Swan, G. W. 1990. Role of optimal control theory in cancer chemotherapy. Math. Biosci. 101, 237-284.
26. gG multiple myeloma. Bull. Math. Biol. 39, 317.
27. Thornton, B. S. 1988. Prescheduling graphic displays for optimal cancer therapies to reveal possible tumor regression or stabilization. J. Med. Syst. 12, 31-41.
28. Vaidya, V. G. and F. J. Alexandro, Jr. 1982. Evaluation of some mathematical models for tumor growth. Int. J. Bio-Med. Comp. 13, 19-35.
29. Vendite, L. L. 1988. Modelagem matemática para o crescimento tumoral e o problema de resistência celular aos fármacos anti-bláticos. Ph.D. thesis, Faculdade de Engenharia Elétrica, Universidade Estadual de Campinas, SP, Brazil.
30. Vietti, T. J. 1980. Evaluation of toxicity: clinical issues. Cancer Treat. Rep. 64, 457-461.
31. Zietz, S. and C. Nicolini. 1979. Mathematical approaches to optimization of cancer chemotherapy. Bull. Math. Biol. 41, 305-324.